Stockreport

Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101

ALLERGAN INC  (AGN) 
Last allergan inc earnings: 2/10 07:00 am Check Earnings Report
US:NYSE Investor Relations: allergan.com/investors
PDF DUBLIN and CAMBRIDGE, Mass., Aug. 6, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. (NASDAQ: EDIT), a [Read more]